7 Nicotinic Acetylcholine Receptor as a Potential Therapeutic Target for Schizophrenia

E-ISSN： 1873-4286|17|2|121-129

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.2, 2011-01, pp. : 121-129

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

7 Nicotinic Receptor Agonists as Potential Therapeutic Drugs for Schizophrenia

Current Medicinal Chemistry - Central Nervous System Agents, Vol. 5, Iss. 3, 2005-09 ,pp. : 171-184

Bentham Science Publishers

Access to resources Recommend Favorite

Nicotinic Receptors and the Treatment of Attentional and Cognitive Deficits in Neuropsychiatric Disorders: Focus on the 7 Nicotinic Acetylcholine Receptor as a Promising Drug Target for Schizophrenia

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 7, Iss. 4, 2007-12 ,pp. : 269-288

Bentham Science Publishers

Access to resources Recommend Favorite

α7 Nicotinic Acetylcholine Receptors: A Therapeutic Target in the Structure Era

Current Drug Targets, Vol. 13, Iss. 5, 2012-01 ,pp. : 695-706

Bentham Science Publishers

Access to resources Recommend Favorite

The therapeutic potential of nicotinic acetylcholine receptor agonists for pain control

By Decker Michael W Meyer Michael D Sullivan James P

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 10, 2001-10 ,pp. : 1819-1830

Informa Healthcare

Access to resources Recommend Favorite

Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia

By Martin Laura Kem William Freedman Robert

Psychopharmacology, Vol. 174, Iss. 1, 2004-06 ,pp. : 54-64

Springer Publishing Company

Access to resources Recommend Favorite